Despite some recent improvements, millions of Americans still face significant barriers in affording GLP-1s. At the same time, many patients have found alternative, cheaper paths to get their hands on unregulated versions. Stephanie Sy reports for our series, GLP-1s: Reshaping America.
Despite some recent improvements, millions of Americans still face significant barriers in affording GLP-1s. At the same time, many patients have found alternative, cheaper paths to get their hands on unregulated versions. Stephanie Sy reports for our series, GLP-1s: Reshaping America.
<iframe src="https://statesidedaily.com/embed/cluster/ed4314cc46def6fe784345f8391a0e2f5e855465" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="High cost of GLP-1s drives some to seek cheaper, unregulated versions"></iframe>
